Logos Global Management LP
Position in GPCR — Structure Therapeutics Inc.
CIK 1792126
San Francisco, CA
Position in GPCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$24,100,000
-$17,630,000 QoQ
Shares Held
500,000
-16.7% QoQ
Ownership
0.234%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Jun 30, 2024CallValue
$17,671,500
CallShares
450,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Logos Global Management LP holds $1,835,814,678 across 59 Biotechnology names. GPCR ranks #26 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,000,000 | $194,500,000 | |
| 2 | ERAS |
Erasca, Inc.
|
11,150,000 | $180,407,000 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
3,450,000 | $114,954,000 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
285,000 | $91,824,150 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
2,125,000 | $84,405,000 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
1,500,000 | $79,080,000 | |
| 7 | ABVX |
Abivax S.A.
|
675,000 | $75,161,250 | |
| 8 | TNGX |
Tango Therapeutics, Inc.
|
3,000,000 | $62,760,000 |
All Filings in GPCR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,100,000 | 500,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,730,000 | 600,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $23,800,000 | 850,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,629,000 | 850,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,356,750 | 425,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,984,000 | 700,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $54,862,500 | 1,250,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $43,197,000 | 1,100,000 | Shares | Sole | 2024-08-27 | |
| 2024-06-30 | $17,671,500 | 450,000 | Call | Sole | 2024-08-27 | |
| 2024-03-31 | $19,287,000 | 450,000 | Call | Sole | 2024-05-15 | |
| 2024-03-31 | $30,861,685 | 720,058 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $43,615,564 | 1,070,058 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,210,000 | 500,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,628,000 | 400,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $8,326,500 | 350,000 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||